The company's Board of Directors has approved a proposal to issue up to 1.25 Cr fully convertible warrants on a private placement basis.

Each warrant, priced at ₹10, is convertible into one equity share of ₹10 face value, aggregating to ₹12.50 Cr.

These warrants will be allotted to promoters and other investors, with a conversion period of 18 months.

The cash proceeds will fuel growth, expansion initiatives, including investments in group entities like Wardwizard Medicare Private Limited, support working capital, and serve general corporate purposes.